These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1387303)
1. Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. de Lalla F; Maserati R; Scarpellini P; Marone P; Nicolin R; Caccamo F; Rigoli R Antimicrob Agents Chemother; 1992 Jul; 36(7):1567-9. PubMed ID: 1387303 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. Kemper CA; Meng TC; Nussbaum J; Chiu J; Feigal DF; Bartok AE; Leedom JM; Tilles JG; Deresinski SC; McCutchan JA Ann Intern Med; 1992 Mar; 116(6):466-72. PubMed ID: 1739237 [TBL] [Abstract][Full Text] [Related]
3. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. Chiu J; Nussbaum J; Bozzette S; Tilles JG; Young LS; Leedom J; Heseltine PN; McCutchan JA Ann Intern Med; 1990 Sep; 113(5):358-61. PubMed ID: 2382918 [TBL] [Abstract][Full Text] [Related]
4. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931 [TBL] [Abstract][Full Text] [Related]
5. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Young LS; Wiviott L; Wu M; Kolonoski P; Bolan R; Inderlied CB Lancet; 1991 Nov; 338(8775):1107-9. PubMed ID: 1682544 [TBL] [Abstract][Full Text] [Related]
6. A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team. Parenti DM; Williams PL; Hafner R; Jacobs MR; Hojczyk P; Hooton TM; Barber TW; Simpson G; van der Horst C; Currier J; Powderly WG; Limjoco M; Ellner JJ AIDS; 1998 Dec; 12(18):2439-46. PubMed ID: 9875582 [TBL] [Abstract][Full Text] [Related]
7. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527 [TBL] [Abstract][Full Text] [Related]
9. Clarithromycin monotherapy of MAC-mycobacteriosis in AIDS patients. Weits J; Sprenger HG; Ilic P; van Klingeren B; Steensma JT Neth J Med; 1991 Aug; 39(1-2):126-7. PubMed ID: 1835763 [No Abstract] [Full Text] [Related]
10. New antibiotics look good against M. avium. Am J Nurs; 1992 Jan; 92(1):12. PubMed ID: 1309625 [No Abstract] [Full Text] [Related]
11. Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Benson CA; Kessler HA; Pottage JC; Trenholme GM Arch Intern Med; 1991 Mar; 151(3):582-5. PubMed ID: 2001140 [TBL] [Abstract][Full Text] [Related]
12. Acquired resistance of MAI to clarithromycin. Ruf B; Schürmann D; Mauch H Am Rev Respir Dis; 1992 May; 145(5):1241-2. PubMed ID: 1533999 [No Abstract] [Full Text] [Related]
13. Unusual pigmentation in patients with AIDS who are receiving rifabutin for bacteremia due to Mycobacterium avium/Mycobacterium intracellulare complex. Smith JF; Flanigan TP Clin Infect Dis; 1995 Dec; 21(6):1515-6. PubMed ID: 8749653 [No Abstract] [Full Text] [Related]
14. MAC management. PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967 [TBL] [Abstract][Full Text] [Related]
15. Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida. May T; Brel F; Beuscart C; Vincent V; Perronne C; Doco-Lecompte T; Saint-Marc T; Dautzenberg B; Grosset J Clin Infect Dis; 1997 Sep; 25(3):621-9. PubMed ID: 9314450 [TBL] [Abstract][Full Text] [Related]
16. Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome. Barradell LB; Plosker GL; McTavish D Drugs; 1993 Aug; 46(2):289-312. PubMed ID: 7691518 [TBL] [Abstract][Full Text] [Related]
18. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Chaisson RE; Benson CA; Dube MP; Heifets LB; Korvick JA; Elkin S; Smith T; Craft JC; Sattler FR Ann Intern Med; 1994 Dec; 121(12):905-11. PubMed ID: 7978715 [TBL] [Abstract][Full Text] [Related]
19. Promising investigational drug available to AIDS patients. Bol Asoc Med P R; 1991 Nov; 83(11):508-9. PubMed ID: 1839821 [No Abstract] [Full Text] [Related]
20. Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection. De Wit S; D'Abbraccio M; De Mol P; Clumeck N Lancet; 1993 Jan; 341(8836):53-4. PubMed ID: 8093299 [No Abstract] [Full Text] [Related] [Next] [New Search]